Haematic antegrade repriming to enhance recovery after cardiac surgery from the perfusionist side
- PMID: 37034100
- PMCID: PMC10062161
- DOI: 10.1051/ject/2023004
Haematic antegrade repriming to enhance recovery after cardiac surgery from the perfusionist side
Abstract
Background: New era of cardiac surgery aims to provide an enhanced postoperative recovery through the implementation of every step of the process. Thus, perfusion strategy should adopt evidence-based measures to reduce the impact of cardiopulmonary bypass (CPB). Hematic Antegrade Repriming (HAR) provides a standardized procedure combining several measures to reduce haemodilutional priming to 300 mL. Once the safety of the procedure in terms of embolic release has been proven, the evaluation of its beneficial effects in terms of transfusion and ICU stay should be assessed to determine if could be considered for inclusion in Enhanced Recovery After Cardiac Surgery (ERACS) programs. Methods: Two retrospective and non-randomized cohorts of high-risk patients, with similar characteristics, were assessed with a propensity score matching model. The treatment group (HG) (n = 225) received the HAR. A historical cohort, exposed to conventional priming with 1350 mL of crystalloid confirmed the control group (CG) (n = 210). Results: Exposure to any transfusion was lower in treated (66.75% vs. 6.88%, p < 0.01). Prolonged mechanical ventilation (>10 h) (26.51% vs. 12.62%; p < 0.01) and extended ICU stay (>2 d) (47.47% vs. 31.19%; p < 0.01) were fewer for treated. HAR did not increase early morbidity and mortality. Related savings varied from 581 to 2741.94 $/patient, depending on if direct or global expenses were considered. Discussion: By reducing the gaseous and crystalloid emboli during CPB initiation, HAR seems to have a beneficial impact on recovery and reduces the overall transfusion until discharge, leading to significant cost savings per process. Due to the preliminary and retrospective nature of the research and its limitations, our findings should be validated by future prospective and randomized studies.
Keywords: Cardiopulmonary Bypass; Enhanced recovery after surgery; Haemodilution, blood conservation; Hematic antegrade repriming; Minimized extracorporeal circuits.
© The Author(s), published by EDP Sciences, 2023.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Hematic Antegrade Repriming Reduces Emboli on Cardiopulmonary Bypass: A Randomized Controlled Trial.ASAIO J. 2023 Mar 1;69(3):324-331. doi: 10.1097/MAT.0000000000001776. Epub 2022 May 23. ASAIO J. 2023. PMID: 35609139 Free PMC article. Clinical Trial.
-
Hematic Antegrade Repriming: A Reproducible Method to Decrease the Cardiopulmonary Bypass Insult.J Extra Corpor Technol. 2021 Mar;53(1):75-79. doi: 10.1182/ject-2000043. J Extra Corpor Technol. 2021. PMID: 33814610 Free PMC article.
-
Impact of On-Bypass Red Blood Cell Transfusion on Severe Postoperative Morbidity or Mortality in Children.Anesth Analg. 2016 Aug;123(2):420-9. doi: 10.1213/ANE.0000000000001425. Anesth Analg. 2016. PMID: 27331784
-
Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults.Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):360-70. doi: 10.1093/icvts/ivt491. Epub 2013 Nov 21. Interact Cardiovasc Thorac Surg. 2014. PMID: 24263581 Free PMC article. Review.
-
[Blood transfusion via the cardiopulmonary bypass circuit: the anesthesiologist point of view].Ann Fr Anesth Reanim. 2014 Apr;33 Suppl 1:S10-3. doi: 10.1016/j.annfar.2014.01.017. Epub 2014 Mar 6. Ann Fr Anesth Reanim. 2014. PMID: 24613767 Review. French.
Cited by
-
2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP.Interdiscip Cardiovasc Thorac Surg. 2025 May 6;40(5):ivae170. doi: 10.1093/icvts/ivae170. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 39385501 Free PMC article. No abstract available.
-
2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP.Eur J Cardiothorac Surg. 2025 May 6;67(5):ezae352. doi: 10.1093/ejcts/ezae352. Eur J Cardiothorac Surg. 2025. PMID: 39385500 Free PMC article. No abstract available.
References
-
- Margarit JAE, Pajares MA, García-Camacho C, Blanco-Morillo J (2020) Vía clínica de recuperación intensificada en cirugía cardiaca. Documento de consenso de la Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR), la Sociedad Española de Cirugía Cardiovascular y Endovascular (SECCE) y la Asociación Española de Perfusionistas (AEP). Cir Cardiovasc 13, 28. - PubMed
-
- Jawitz OK, Bradford WT, McConnell G, Engel J, Allender JE, Williams JB (2020) How to start an enhanced recovery after surgery cardiac program. Crit Care Clin 36(4), 571–579. - PubMed
-
- Yazdchi F, Hirji S, Harloff M, et al. (2022) Enhanced recovery after cardiac surgery: a propensity-matched analysis. Semin Thorac Cardiovasc Surg 34(2), 585–594. - PubMed
-
- Puis L, Milojevic M, Boer C, et al. (2019) EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Interact CardioVasc Thorac Surg [Internet] 59, 12–53. [cited 2019 Nov 20]; Available from: https://academic.oup.com/icvts/advance-article/doi/10.1093/icvts/ivz251/.... - DOI - PMC - PubMed
-
- Menkis AH, Martin J, Cheng DCH, et al. (2012) Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations (Phila) 7(4), 229–241. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous